Table 2.
Number,mean of exacerbations and number of patients (in parentheses) at each study visit
| V1 | V2 | V3 | V4 | V5 | |
|---|---|---|---|---|---|
| Statin users (SU) | 538 (n = 413) 1.30 | 332 (n = 366) 0.91 | 287 (n = 317) 0.91 | 358 (n = 220) 1.63 | 144 (n = 152) 0.95 |
| Statin naïve (SN) | 1742 (n = 1306) 1.33 | 1114 (n = 1122) 0.99 | 995 (n = 946) 1.05 | 755 (n = 643) 1.17 | 529 (n = 476) 1.11 |
| Incident-statins (IS) | 159 (n = 168) 0.95 | 167 (n = 165) 1.01 | 291 (n = 164) 1.77 | 199 (n = 147) 1.35 | 167 (n = 118) 1.42 |
Number of acute exacerbations at each study visit V1-V5
n = number of patients at each visit. The percentages refer to the proportion of exacerbations based on the number of patients